Page last updated: 2024-09-02

ecteinascidin 743 and Liver Neoplasms

ecteinascidin 743 has been researched along with Liver Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baresic, T; Buonadonna, A; Canzonieri, V; Corona, G; Lara, DP; Miolo, G; Santeufemia, DA; Viel, A	1
Adam, J; Ahlenc-Gelas, M; Cavalcanti, A; Domitrescu, G; Dumont, S; El Amarti, L; Honore, C; Kiavue, N; Klausner, G; Le Cesne, A; Mir, O; Sourrouille, I; Terrier, P; Verret, B	1
Butkiewicz, L; Demetri, GD; Garcia-Carbonero, R; Guzman, C; Harmon, D; Jimeno, J; Lopez-Lazaro, L; Maki, RG; Puchalski, TA; Ryan, DP; Seiden, MV; Supko, JG	1
Brain, E; Jimeno, J; Misset, JL; Riofrio, M; Spielmann, M; Taamma, A; Turpin, F; Yovine, A; Zelek, L	1

Trials

2 trial(s) available for ecteinascidin 743 and Liver Neoplasms

Article	Year
Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity. Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:4 Topics: Adult; Antineoplastic Agents; Dexamethasone; Dioxoles; Humans; Infusions, Intravenous; Isoquinolines; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Neutropenia; Sarcoma; Tetrahydroisoquinolines; Trabectedin; Transaminases	2002
A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer. British journal of cancer, 2006, Jun-05, Volume: 94, Issue:11 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Breast Neoplasms; Dioxoles; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Isoquinolines; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Tetrahydroisoquinolines; Trabectedin	2006

Article

Year

Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity.

Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:4

Topics: Adult; Antineoplastic Agents; Dexamethasone; Dioxoles; Humans; Infusions, Intravenous; Isoquinolines; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Neutropenia; Sarcoma; Tetrahydroisoquinolines; Trabectedin; Transaminases

2002

A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer.

British journal of cancer, 2006, Jun-05, Volume: 94, Issue:11

Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Breast Neoplasms; Dioxoles; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Isoquinolines; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Tetrahydroisoquinolines; Trabectedin

2006

Other Studies

2 other study(ies) available for ecteinascidin 743 and Liver Neoplasms

Article	Year
Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma. Cancer biology & therapy, 2016, 10-02, Volume: 17, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bone Neoplasms; BRCA2 Protein; Dioxoles; Endometrial Neoplasms; Epirubicin; Female; Genes, BRCA2; Germ-Line Mutation; Humans; Ifosfamide; Liver Neoplasms; Middle Aged; Mutation, Missense; Sarcoma, Endometrial Stromal; Tetrahydroisoquinolines; Trabectedin	2016
Trabectedin in advanced desmoplastic round cell tumors: a retrospective single-center series. Anti-cancer drugs, 2017, Volume: 28, Issue:1 Topics: Adult; Antineoplastic Agents, Alkylating; Desmoplastic Small Round Cell Tumor; Dioxoles; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Pleural Neoplasms; Retrospective Studies; Tetrahydroisoquinolines; Trabectedin; Young Adult	2017

Article

Year

Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma.

Cancer biology & therapy, 2016, 10-02, Volume: 17, Issue:10

Topics: Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bone Neoplasms; BRCA2 Protein; Dioxoles; Endometrial Neoplasms; Epirubicin; Female; Genes, BRCA2; Germ-Line Mutation; Humans; Ifosfamide; Liver Neoplasms; Middle Aged; Mutation, Missense; Sarcoma, Endometrial Stromal; Tetrahydroisoquinolines; Trabectedin

2016

Trabectedin in advanced desmoplastic round cell tumors: a retrospective single-center series.

Anti-cancer drugs, 2017, Volume: 28, Issue:1

Topics: Adult; Antineoplastic Agents, Alkylating; Desmoplastic Small Round Cell Tumor; Dioxoles; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Pleural Neoplasms; Retrospective Studies; Tetrahydroisoquinolines; Trabectedin; Young Adult

2017